Shukla Sanjay bought ATYR
January 9, 2026 · Form 4 insider transaction
Shukla Sanjay bought 1,500,000 shares of aTyr Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,500,000
Price
$0.00
Total value
N/A
InsiderShukla Sanjay
RoleOfficer, Director
CompanyaTyr Pharma, Inc. (ATYR)
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 9, 2026
Filing dateJanuary 9, 2026
Shares owned after1,500,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning February 9, 2026, such that this option will be fully exercisable on January 9, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.